Clinical Trials in San Antonio

Showing 9461-9480 of 14,633 trials

High-dose Aldosterone Antagonist for Acute Decompensated Heart Failure

NCT02823626

Primary Aims 1. Evaluate the safety of high-dose spironolactone in combination of patiromer in acute decompensated heart failure patients. 2. Evaluate the efficacy of high-dose spironolactone in combination of patiromer in causing volume loss and symptom relief in patients with ADHF treated with high-dose spironolactone. Secondary Aims 1: Evaluate the effect of high-dose spironolactone on urinary sodium excretion and renal function.

Acute Decompensated Heart Failure

The University of Texas Health Science Center at San Antonio48 participantsStarted Sep 2016

San Antonio, Texas, United States

COMPLETEDPhase 2< 1 mile

Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis

NCT02780167

Study B7451006 is a Phase 2b POC study which is planned to assess four PF 04965842 once daily (QD) doses (10, 30, 100, 200 mg) relative to placebo over 12 weeks to characterize the efficacy and safety of PF 04965842 in subjects with moderate to severe AD. The objectives of the study are to demonstrate the efficacy of PF 04965842 by showing improvement in disease severity in patients with moderate to severe AD as measured by the Investigator's Global Assessment (IGA) and Eczema Area and Severity Index (EASI) scores, and safety to support further clinical development of PF 04965842.

Atopic Dermatitis

Pfizer269 participantsStarted Apr 2016

Birmingham, Alabama, United States • Encinitas, California, United States • Pasadena, California, United States +61 more locations

High-dose Aldosterone Antagonist for Acute Decompensated Heart Failure

Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis

Find Trials by Condition in San Antonio

Building a Healthy Temple: a Diabetes Self-management Support Program in Hispanic Faith Community Settings

A Phase2 of A-101 Topical Solution in Subjects With Common Warts

The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects

Oral Immunomodulatory Tyrosine Kinase Inhibitor in Patients With Locally Advanced or Metastatic Solid Tumors

Respiratory Resistance Training on Sleep Quality in Persons With Spinal Cord Injury

Long-term Safety and Efficacy of Sirukumab in Participants With RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003

Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump

Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease.

A Evaluation of 3D Functional MIRA System in Women With Mammographically Dense Breasts

Study Evaluating Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: The HEADWAY-DLB Study

Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris

A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas

MEmbranous Nephropathy Trial Of Rituximab

A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors

Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer

A Study to Investigate the Safety and Efficacy of Lacosamide Added to the Patients Current Therapy in Patients Aged 1 Month to Less Than 18 Years Old With Epilepsy Syndromes Associated With Generalized Seizures.

A Phase 2a, Proof-of-Concept Study of GIC-1001 in the Management of Visceral Pain During Sedation-Free, Full Colonoscopy

A Study Evaluating the Safety and Efficacy of the LentiGlobin BB305 Drug Product in β-Thalassemia Major Participants